Pharmacogenomics Market PDF, Size, Share | Industry Trends Report 2021-2026

1. Global Pharmacogenomics Market Research Report and Forecast 2021-2026 Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2019 IMARC All Rights Reserved

2. Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value challenges, and transform their businesses. opportunities, address their most critical IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description Global Pharmacogenomics Market Outlook 2026: According to the latest report by IMARC Group, titled “Pharmacogenomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global pharmacogenomics market experienced moderate growth during 2015-2020. Pharmacogenomics is a field of research that studies the relation between the deoxyribonucleic acid (DNA) of an individual and their response to a drug. It helps healthcare providers to select and develop safe, effective medications that can be tailored to the genetic design of a person. Pharmacogenomics studies variations in certain proteins, such as liver enzymes, that affect the performance of a drug. The drug development process through pharmacogenomics consists of various analyses, which include drug receptors, drug uptake, drug breakdown, and targeted drug development. Overall, it decreases healthcare costs via reduced adverse drug reactions, minimal number of failed clinical trials, and lesser time consumption in the drug approval process. Pharmacogenomics also helps in designing precise methods of measuring appropriate drug dosages and the development of more efficient vaccines. Request for a free sample: https://www.imarcgroup.com/pharmacogenomics-market/requestsample

4. Report Description and Highlights Report Description Global Pharmacogenomics Market Trends: A significant rise in the research and development (R&D) expenditure activities and an increase in the instances of adverse reactions of drugs are some of the primary factors that are currently driving the global pharmacogenomics market growth. Additionally, there is a rising preference toward precision medicine on account the emerging need for improved drug efficacy and safety, which is further contributing to the growth of the market. Other than this, the increasing prevalence of different types of cancer is also fueling the market growth as targeted therapy has proven to improve the survival rates of patients and decrease redundant costs. Moreover, rapid technological advancements have resulted in the introduction of newer and upgradation of existing laboratories, which is attracting numerous investors from across the healthcare industry, thereby creating a positive outlook for the market.

5. Report Description and Highlights Report Description Market Summary: Breakup by Technology: • Polymerase Chain Reaction • Microarray • DNA Sequencing • Mass Spectrometry • Electrophoresis Breakup by Application: • Oncology • Infectious Diseases • Cardiovascular Diseases • Neurological Diseases • Psychiatry • Pain Management

6. Report Description and Highlights Report Description Breakup by End User: • Hospitals and Clinics • Academic and Research Institutes Breakup by Region: • North America • Asia Pacific • Europe • Middle East and Africa • Latin America Looking forward, IMARC Group expects the market to grow at a CAGR of around 7% during 2021-2026.

7. Report Description and Highlights Report Description Competitive Landscape With Key players: • Abbott Laboratories • AstraZeneca plc • Bayer AG • Becton Dickinson and Company • Bio-Rad Laboratories Inc • F. Hoffmann-La Roche AG • GlaxoSmithKline plc • Illumina Inc • Johnson & Johnson • Merck KGaA • Myriad Genetics Inc • Qiagen N.V • Thermo Fisher Scientific Inc View Report TOC, Figures and Tables: https://www.imarcgroup.com/pharmacogenomics-market

8. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

9. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

10. Report Description and Highlights Report Description © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

11. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com